
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Notum CRISPR/Cas9 KO Plasmid (m) | sc-429545 | 20 µg | $397.00 |
Notum encodes a secreted carboxylesterase that attenuates Wnt signaling by deacylating the palmitoleate group on Wnt ligands, thereby reducing ligand–receptor engagement and downstream β-catenin–dependent transcription. In mouse, NOTUM contributes to regulation of embryonic patterning, tissue homeostasis, and stem cell niche activity through modulation of canonical Wnt/Frizzled–LRP signaling. Altered NOTUM activity has been linked to dysregulated Wnt pathway output in contexts such as bone remodeling, intestinal epithelial dynamics, and neurodevelopmental processes. As a Wnt pathway brake, Notum is frequently studied in pathway feedback regulation and microenvironmental control of proliferation and differentiation.
Notum CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Notum gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Notum together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Notum open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Notum protein expression.
This CRISPR knockout system enables efficient generation of Notum-deficient cell models for investigation of Notum signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.